secwatch / observer

8-K filed February 2, 2026, 6:59 PM ET ticker IDAI CIK 0001718939

other material confidence high sentiment positive materiality 0.75

Trust Stamp signs non-binding LOIs for two M&A deals; secures first IT2 PO from African telecom

T Stamp Inc

Two non-binding LOIs to acquire a UK cybersecurity startup outright and take 50% stake in another; no cash, dilution <2.5%; close by end of Feb.
First Purchase Order for Irreversibly Transformed Identity Token (IT2) from a large African telecom; expected to generate 7-figure ARR at maturity.
Anchor S&P 500 bank engagement extended six years; estimated 2026 gross annualized revenues of $2.4M-$2.7M.
Orchestration Layer platform enrollment at 112 institutions; total transaction volumes up ~20% in 2025, FIS-related transactions up ~200%.
WoW Stablecoin wallet MVP delivered; LOI signed with a Nasdaq-listed company for first deployment; Swiss Trust Valley program underway.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-009120
form_type: 8-K
ticker: IDAI
cik: 0001718939
company_name: T Stamp Inc
filed_at: 2026-02-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.994132+00:00
generated_at: 2026-05-16T05:38:57.096575+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-009120
json_url: https://secwatch.observer/filing/0001104659-26-009120.json
markdown_url: https://secwatch.observer/filing/0001104659-26-009120.md
text_url: https://secwatch.observer/filing/0001104659-26-009120.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1718939/000110465926009120/0001104659-26-009120-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1718939/000110465926009120/tm264636d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

XMTR

Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M

Xometry, Inc. June 2, 2026, 5:26 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

HYMC

Hycroft TRS shows $10B NPV at spot; 51-year mine life with 10.4M oz gold

HYCROFT MINING HOLDING CORP June 2, 2026, 4:31 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TTI

TETRA announces $100M common stock offering, Arkansas Bromine Project approved with $220M remaining capex

TETRA TECHNOLOGIES INC June 2, 2026, 4:26 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CEG

Constellation Energy secondary offering of 11M shares with concurrent $558M share repurchase

Constellation Energy Corp June 2, 2026, 4:15 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CNL Strategic Capital, LLC

Shareholders reject enhanced liquidity plan (25% repurchase); loan amended for equity buybacks

CNL Strategic Capital, LLC June 2, 2026, 4:04 PM ET other_material Items 1.01, 2.03, 5.07, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

INMB

INmune Bio reports statistically significant white matter MRI biomarker in Phase 2 Alzheimer's trial

Inmune Bio, Inc. June 2, 2026, 4:00 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

QMCO

Quantum raises $100M equity, converts all convertible notes to equity; Q4 revenue above guidance

QUANTUM CORP /DE/ June 2, 2026, 10:41 AM ET other_material Items 1.01, 2.02, 2.03, 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CELC

Gedatolisib doubles PFS vs alpelisib in PIK3CA mutant HR+/HER2- ABC Phase 3 trial

Celcuity Inc. June 2, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-26-009120

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.